What is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey

dc.contributor.authorBalin, Safak O.
dc.contributor.authorKazanci, Ulku
dc.contributor.authorDemirdag, Kutbeddin
dc.contributor.authorAkbulut, Ayhan
dc.date.accessioned2026-08-12T17:20:29Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.description.abstractAim: We aimed to determine the prognostic performance of the Glasgow Prognostic Score (GPS), systemic immune-inflammation index and early warning score (the 'ANDC' system) in patients with diabetes mellitus who had COVID-19. Patients & methods: Patients were divided into two groups: with and without diabetes mellitus. Results: In the diabetic patient group, the rates of in-hospital mortality, intensive care unit hospitalization and corticosteroid treatment were higher compared with the nondiabetic patient group (p < 0.05). A GPS of 2 was useful for predicting in-hospital mortality in diabetic patients (p < 0.05). The ANDC score was significantly higher in diabetic patients (p < 0.05) and in diabetic patients with mortality and those who needed ICU hospitalization (p < 0.05). Conclusion: The presence of a GPS of 2 at the time of admission and a high ANDC value were associated with poor prognosis in diabetic COVID-19 patients.
dc.identifier.doi10.2217/bmm-2022-0250
dc.identifier.endpage979
dc.identifier.issn1752-0363
dc.identifier.issn1752-0371
dc.identifier.issue13
dc.identifier.orcid0000-0003-2560-3265
dc.identifier.pmid36006030
dc.identifier.scopus2-s2.0-85138125526
dc.identifier.scopusqualityQ2
dc.identifier.startpage971
dc.identifier.urihttps://doi.org/10.2217/bmm-2022-0250
dc.identifier.urihttps://hdl.handle.net/11508/53574
dc.identifier.volume16
dc.identifier.wosWOS:000844566800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherFuture Medicine Ltd
dc.relation.ispartofBiomarkers in Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCOVID-19
dc.subjectdiabetes mellitus
dc.subjectearly warning score
dc.subjectGlasgow prognostic score
dc.subjectsystemic immune-inflammation index
dc.titleWhat is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey
dc.typeArticle

Dosyalar